Vigonvita Life Sciences

This is an early-stage study to check the safety and how the body processes a new potential schizophrenia medication called VV119. It will first test the drug in healthy adults, then in a small group of patients with schizophrenia to see if it is safe and how it affects their sym…

This early-stage study aims to understand how eating a standard meal affects how the body absorbs and processes a single dose of an investigational capsule called VV119. It will involve 16 healthy Chinese adult volunteers who will take the capsule either with or without food in a…

This is the first study in people for a new drug called VV261. Its main purpose is to check the safety and see how the body absorbs and eliminates the drug. The study will enroll 58 healthy volunteers in China who will receive a single dose of either the drug or a placebo. Resear…